(ANSA) - BRUSSELS, APRIL 07 - The preliminary time of the press conference of the European Medicines Agency on the new evaluation of the pharmacovigilance commission (Prac) of the AstraZeneca vaccine, in relation to rare events of cerebral thrombosis, is set for today at 4 pm This was announced by the EMA in a note.
(HANDLE).